Detection of IL-17 and IL-23 in plasma samples of children with autism

American Journal of Biochemistry and Biotechnology

Volumn 4, Issue 2, 2008, Pages 114-120

  Enstrom, Amanda ^a   Onore, Charity ^a   Hertz Picciotto, Irva ^a   Hansen, Robin ^b   Croen, Lisa ^c   Van De Water, Judy ^b   Ashwood, Paul ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; IL 23; Inflammation; Neurodevelopment; Th 17 cells

Indexed keywords

CELLS; DISEASES; IMMUNOLOGY;

AUTISM; INFLAMMATION; NEURODEVELOPMENT;

PLASMA (HUMAN);

INTERLEUKIN 17; INTERLEUKIN 23;

ARTICLE; AUTISM; BLOOD SAMPLING; CELL COUNT; CELL FUNCTION; CELL SURVIVAL; CHILD DEVELOPMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRESCHOOL CHILD; PROTEIN DETERMINATION; REMISSION; T LYMPHOCYTE;

EID: 42449120078     PISSN: 15533468     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajbbsp.2008.114.120     Document Type: Article

References (42)

1. Ashwood, P., S. Wills and J. Van De Water, 2006. The immune response in autism: a new frontier for autism research. J. Leukocyte Biol., 80: 1-15
2. Cohly, H.H.P. and A. Panja, 2005. Immunological findings in autism. Int. Rev. Neurobiol., 71: 317-341
3. Korvatska, E., J. Van de Water, T.F. Anders and M.E. Gershwin, 2002. Genetic and immunologic considerations in autism. Neurobiol. Dis., 9: 107-125
4. Croonenberghs, J., E. Bosmans, D. Deboutte, G. Kenis and M. Maes, 2002. Activation of the inflammatory response system in autism. Neuropsychobiology, 45: 1-6.
5. Jyonouchi, H., S.N. Sun and H. Le, 2001. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol., 120: 170-179
6. Ashwood, P. and A.J. Wakefield, 2006. Immune activation of peripheral blood and mucosal CD3(+) lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J. Neuroimmunol. 173: 126-134
7. Vargas, D.L., C. Nascimbene, C. Krishnan, A.W. Zimmerman and C.A. Pardo, 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurobiol., 57: 67-81
8. Aggarwal, S., N. Ghilardi, M.H. Xie, F.J. de Sauvage and A.L. Gurney, 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem., 278: 1910-1914
9. Langrish, C.L., Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, J.D. Sedgwick, T. McClanahan, R.A. Kastelein and D.J. Cua, 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med., 201: 233-240
10. Veldhoen, M., R.J. Hocking, C.J. Atkins, R.M. Locksley and B. Stockinger, 2006. TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity, 24: 179-189
11. Harrington, L.E., R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, K.M. Murphy and C.T. Weaver, 2005. Interleukin 17-producing CD4(+) effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol., 6: 1123-1132
12. Bettelli, E., Y.J. Carrier, W.D. Gao, T. Korn , T.B. Strom, M. Oukka, H.L. Weiner and V.K. Kuchroo, 2006. Reciprocal developmental pathways for the generation of pathogenic effector T(H)17 and regulatory T cells. Nature, 441: 235-238
13. Mangan, P.R., L.E. Harrington, D.B. O'Quinn, W.S. Helms, D.C. Bullard, C.O. Elson, R.D. Hatton, S.M. Wahl, T.R. Schoeb and C.T. Weaver, 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature, 441: 231-234
14. Hue, S., P. Ahern, S. Buonocore, M.C. Kullberg, D.J. Cua, B.S. McKenzie, F. Powrie and K.J. Maloy, 2006. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med., 203: 2473-2483
15. Fujino, S., A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba and Y. Fujiyama, 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut, 52: 65-70
16. Yen, D., J. Cheung, H. Scheerens, F. Poulet, T. McClanahan, B. Mckenzie, M.A. Kleinschek, A. Owyang, J. Mattson, W. Blumenschein, E. Murphy, M. Sathe, D.J. Cua, R.A. Kastelein and D. Rennick, 2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest., 116: 1310-1316.
17. Murphy, C.A., C.L. Langrish, Y. Chen, C. Blumenschein, T. McClanahan, R.A. Kastelein, J.D. Sedgwick and D.J. Cua, 2003. Divergent proand Antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med., 198: 1951-1957
18. Sato, K., A. Suematsu, K. Okamoto, A. Yamaguchi, Y. Morishita, Y. Kadono, S. Tanaka, T. Kodama, S. Akira, Y. Iwakura, D.J. Cua and H. Takayanagi, 2006. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med., 203: 2673-2682
19. Chabaud, M., P. Garnero, J.M. Dayer, P.A. Guerne, F. Fossiez and P. Miossec, 2000. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine, 12: 1092-1099
20. Lock, C., G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, P. Klonowski, A. Austin, N. Lad, N. Kaminski, S.J. Galli, J.R. Oksenberg, C.S. Raine, R. Heller and L. Steinman, 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med., 8: 500-508
21. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo and Y. Iwakura, 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol., 177: 566-573
22. Chen, Y., C.L. Langrish, B. Mckenzie, B. Joyce-Shaikh, J.S. Stumhofer, T. McClanahan, W. Blumenschein, T. Churakovsa, J. Low, L. Presta, C.A. Hunter, R.A. Kastelein and D.J. Cua, 2006. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest.,116: 1317-1326
23. Rohn, T.A., G.T. Jennings, M. Hernandez, P. Grest, M. Beck, Y. Zou, M. Kopf and M.F. Bachmann, 2006. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur. J. Immunol., 36: 2857-2867
24. Koenders, M.I., E. Lubberts, B. Oppers-Walgreen, L. van den Bersselaar, M.M. Helsen, F.E. Di Padova, A.M.H. Boots, H. Gram, L.A.B. Joosten and W.B. van den Berg, 2005. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am. J. Pathol., 167: 141-149
25. Oppmann, B., R. Lesley, B. Blom, J.C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, F. Zonin, E. Vaisberg, T. Churakova, M.R. Liu, D. Gorman, J. Wagner, S. Zurawski, Y.J. Liu, J.S. Abrams, K.W. Moore, D. Rennick, R. de Waal-Malefyt, C. Hannum, J.F. Bazan and R.A. Kastelein, 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity, 13: 715-725
26. Cua, D.J., J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, S. Zurawski, M. Wiekowski, S.A. Lira, D. Gorman, R.A. Kastelein and J.D. Sedgwick, 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature, 421: 744-748
27. Zhang, G.X., B. Gran, S. Yu, J.F. Li, I. Siglienti, X.H. Chen, M. Kamoun and A. Rostami, 2003. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol., 170: 2153-2160
28. Gran, B., G.X. Zhang, S. Yu, J.F. Li, X.H. Chen, E.S. Ventura, M. Kamoun and A. Rostami, 2002. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: Evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol., 169: 7104-7110
29. Li, M.O., Y.Y. Wan, S. Sanjabi, A.K.L. Robertson and R.A. Flavell, 2006. Transforming growth factor-beta regulation of immune responses. Ann. Rev. Immunol., 24: 99-146
30. Stumhofer, J.S., A. Laurence, E.H. Wilson, E. Huang, C.M. Tato, L.M. Johnson, A.V. Villarino, Q. Huang, A. Yoshimura, D. Sehy, C.J.M. Saris, J. O'Shea, L. Hennighausen, M. Ernst and C.A. Hunter, 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7: 937-945
31. Hertz-Picciotto, I., Croen L.A., R. Hansen, C.R. Jones, J. Van de Water and I.N. Pessah, 2006. The CHARGE study: An epidemiologic investigation of genetic and environmental factors contributing to autism. Env. Health Persp., 114: 1119-1125
32. Lord, C., A. Pickles, J. McLennan, M. Rutter, J. Bregman, S. Folstein, E. Fombonne, M. Leboyer and N. Minshew, 1997. Diagnosing autism: Analyses of data from the autism diagnostic interview. J. Autism Devel. Disord., 27: 501-517
33. Lord, C., S. Risi, L. Lambrecht, E.H. Cook, B.L. Leventhal, P.C. DiLavore, A. Pickles and M. Rutter, 2000. The Autism Diagnostic Observation Schedule-Generic: A standard measure of social and communication deficits associated with the spectrum of autism. J. Autism Devel. Disord., 30: 205-223
34. Joseph, R.M., H. Tager-Flusberg and C. Lord, 2006. Cognitive profiles and social-communicative functioning in children with autism spectrum disorder. J. Child Psychol. Psychiatr. Allied Disciplines, 43: 807-821
35. Lord, C, Leventhal BL and EH Cook, 2001. Quantifying the phenotype in autism spectrum disorders. Am. J. Med. Genet., 105: 36-38
36. Owley, T., W. McMahon, E.H. Cook, T. Laulhere, M. South, L.Z. Mays, E.S. Shernoff, J. Lainhart, C.B. Modahl, C. Corsello, S. Ozonoff, S. Risi, C. Lord, B.L. Leventhal and P.A. Filipek, 2001. Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. J. Am. Acad. Child Adolesc. Phychiatr., 40: 1293-1299
37. Berument, S.K., M. Rutter, C. Lord, A. Pickles and A. Bailey, 1999. Autism screening questionnaire: Diagnostic validity. Brit. J. Psychol., 175: 444-451
38. Mullen, E.M., 1995. Mullen scales of early learning. Circle Pines, MN: American Guidance Services, Inc.
39. Sparrow, S.S., D.A. Balla and D.V. Cicchetti, 1984. Vineland adaptive behavior scales interview edition expanded form manual. Circle Pines, MN: American Guidance Services, Inc.
40. Finnerty, C.C., D.N. Herndon, R. Przkora, C.T. Pereira, H.M. Oliveira, D.M.M. Queiroz, A.M.C. Rocha and M.G. Jeschke, 2006. Cytokine expression profile over time in severely burned pediatric patients. Shock, 26: 13-19
41. Ziv, Y., N. Ron, O. Butovsky, G. Landa, E. Sudai, N. Greenberg, H. Cohen, J. Kipnis and M. Schwartz, 2006. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci., 9: 268-275
42. Rogers, S.J., 2004. Developmental regression in autism spectrum disorders. Mental Retard. Devel. Disabilities Res. Rev., 10: 139-143.